lncRNAs and microRNAs with a role in cancer development

Julia Liz1, Manel Esteller2

  • 1Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Barcelona, Catalonia, Spain.

Insights

Long non-coding RNAs (lncRNAs) are crucial in human cancer, with interactions between lncRNAs and microRNAs offering new insights into tumorigenic processes and regulatory mechanisms.

Area of Science:

  • Molecular Biology
  • Genomics
  • Cancer Research

Background:

  • Human diseases, including cancer, exhibit altered transcription patterns.
  • Transcriptome alterations involve both protein-coding and non-coding RNAs.
  • The human genome is largely transcribed into non-coding RNAs (ncRNAs), with less than 2% encoding proteins.

Purpose of the Study:

  • To review mechanistic aspects of long non-coding RNAs (lncRNAs) in human cancer.
  • To highlight the interplay between lncRNAs and microRNAs in tumorigenesis.
  • To provide insights into regulatory mechanisms of ncRNAs, such as transcribed ultraconserved regions (T-UCRs), in cancer.

Main Methods:

  • Review of recent RNA-seq data on the human transcriptome.
  • Analysis of mechanistic roles of specific lncRNAs in cancer.
  • Focus on interactions between lncRNAs and microRNAs.

Main Results:

  • lncRNAs play critical roles in human cancer development.
  • The interaction between lncRNAs and microRNAs is significant in the tumorigenic process.
  • Specific ncRNA classes, including T-UCRs, are important in cancer regulation.

Conclusions:

  • lncRNAs are key regulators in human cancer.
  • Understanding lncRNA-microRNA interactions provides novel insights into cancer mechanisms.
  • Further research into ncRNA classes like T-UCRs is essential for cancer biology.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

12.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K